SIREN : 501217756
IMHOTEP is a French company founded 18 years ago, specialized in the sector Activités de radiodiagnostic et de radiothérapie. Based in LYON (69008), this company of category GE shows in 2025 a revenue of 4.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-08-08
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Aucun signal de fragilité majeur : rentabilité positive et structure financière équilibrée.
In summary, IMHOTEP combines a growing business with positive profitability. Its financial structure is broadly in line with its sector.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 013 163 € | 4 312 700 € | 3 923 950 € | 3 622 754 € | 3 355 245 € | 2 955 567 € | 2 600 950 € | N/C | 2 508 550 € | 2 401 650 € |
| Net income | 1 353 289 € | 1 642 105 € | 1 447 533 € | 1 368 049 € | 1 270 274 € | 1 130 526 € | 897 426 € | 857 060 € | 780 539 € | 661 359 € |
| EBITDA | 1 826 917 € | 2 208 990 € | 1 945 158 € | 1 846 746 € | 1 760 142 € | 1 597 864 € | 1 301 674 € | N/C | 1 076 496 € | 1 079 054 € |
| Net margin | 33.7% | 38.1% | 36.9% | 37.8% | 37.9% | 38.3% | 34.5% | N/C | 31.1% | 27.5% |
In 2025, IMHOTEP achieves revenue of 4.0 M€. Revenue is growing positively over 10 years (CAGR: +4.6%). Slight decline of -7% vs 2024. After deducting consumption (896 k€), gross margin stands at 3.1 M€, i.e. a rate of 78%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.8 M€, representing 45.5% of revenue. Warning negative scissor effect: despite revenue change (-7%), EBITDA varies by -17%, reducing margin by 5.7 pts. This reflects costs rising faster than revenue. Compared with its sector, this ratio places the company among the best positioned (sector median: 16.0%). Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.4 M€, i.e. 33.7% of revenue. This profit can be retained or distributed to shareholders.
4 013 163 €
3 117 396 €
1 826 917 €
1 804 605 €
1 353 289 €
45.5%
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This ratio is slightly less favorable than the sector median (0.5%). Financial autonomy (= Equity / Total assets x 100) reaches 85%. Compared with its sector, this ratio places the company among the best positioned (sector median: 60.3%). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This ratio is more favorable than the sector median (0.5 years). Cash flow represents 34.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Compared with its sector, this ratio places the company among the best positioned (sector median: 13.2%).
0.73%
84.57%
34.27%
0.01
33.2%
In 2025, the debt ratio of IMHOTEP (0.7%) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of IMHOTEP (84.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of IMHOTEP (0.01) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 6.13. Compared with its sector, this ratio places the company among the best positioned (sector median: 2.9).
6.13
0.0
In 2025, the liquidity ratio of IMHOTEP (6.13) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of IMHOTEP (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 2 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 34 days. Excellent situation: suppliers finance 32 days of the operating cycle (retail model). Overall, WCR represents 12 days of revenue, i.e. 135 k€ to permanently finance.
135 123 €
2 j
34 j
0 j
12 j
Based on 274 transactions of similar company sales (all years), the value of IMHOTEP is estimated at 4 864 657 € (range 1 795 120€ - 10 838 552€). With an EBITDA of 1 826 917€, the sector multiple of 3.6x is applied. The price/revenue ratio is 0.43x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 274 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare IMHOTEP with other companies in the same sector:
Voir toutes les statistiques du secteur Activités de radiodiagnostic et de radiothérapie
Largest companies by revenue in the sector Activités de radiodiagnostic et de radiothérapie:
Largest companies by revenue in the department Rhone:
The revenue of IMHOTEP in 2025 is 4.0 M€.
Yes, IMHOTEP generated a net profit of 1.4 M€ in 2025.
The headquarters of IMHOTEP is located in LYON (69008), in the department Rhone.
The tax return of IMHOTEP is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
IMHOTEP operates in the sector Activités de radiodiagnostic et de radiothérapie (NAF code 86.22A). See the 'Sector positioning' section above to compare the company with its competitors.